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Abstract
An individual’s genetic constitution and lifestyle, e.g., diet and levels of physical 
activity, can affect the body’s response to various exogenous agents including therapeu­
tic treatments. The aim of our study was to compare on molecular and cellular levels, 
responses to the X-rays of peripheral blood lymphocytes from colorectal cancer patients 
(CCP) with the results from a group of cancer free controls. We wanted to find out if their 
molecular and cellular radiosensitivity can be associated with predisposition to cancer 
induction or predict efficiency of therapeutic treatment.
On the molecular level, the alkaline version of the single cells gel electrophoresis 
(SCGE) assay, also known as a Comet assay, was used to estimate the DNA damage and 
repair efficiency. The results were compared with the findings of classical cytogenetic
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studies on chromosome and chromatid type aberrations. On average, no significant dif­
ference neither in susceptibility to the challenging dose, nor in the DNA repair efficiency 
was found between investigated groups, although DNA repair efficiency was signifi­
cantly lower than that observed for cells from healthy donors. The findings correlated 
with the results from cytogenetic studies. Higher amounts of chromosome and chromatid 
aberrations were detected in irradiated lymphocytes from colorectal cancer patients than 
in lymphocytes from controls, although the difference between investigated groups was 
statistically insignificant. Our previous results, suggested a possible value of the DNA 
repair in epidemiology as a potentially useful test for prediction of cancer predisposition 
and in pre-clinical studies as a predictor for patient’s response to therapy, and radio­
therapy in particular. As results of the studies have shown some variations due to gender 
and lifestyle factors (smoking history, sport activities) further investigations are needed 
to confirm those observations in larger group of patients.
Introduction
Colorectal cancer (CRC) is one of the most commonly occurring malignancies in both 
men and women (18). The poor prognosis for patients with advanced CRC has led to 
the intensive search for new technologies to enable earlier diagnosis and improve treat­
ment results. The study by Richter et al. summarized chromosomal changes detectable 
in nonpolypoid adenomas of the colon. The authors have demonstrated the presence 
of distinct differences between nonpolypoid and polypoid adenomas, which supported 
observations from the earlier genetic and microsatellite studies, that different genetic 
pathways for tumor progression may exist for colorectal neoplasms of polypoid and non- 
polypoid phenotype. Their study stimulated further search for the new gene alterations 
in nonpolypoid adenomas. The identification of molecular biomarkers specific to early 
and late events in colorectal cancer progression might be critical for the development 
of preventive strategies and improve disease detection. On the other hand, biomarker 
of patient cellular sensitivity (i.e., DNA or cellular response to genotoxic agents) might 
be used as a prognostic predictor in treatment planning. Chromosome damage in hu­
man lymphocytes, very well known biomarker in human monitoring, was first used in 
1962 to examine the risk associated with radiation accidental exposure (13, 17). Recent 
studies (11, 13) have shown positive and statistically significant association between 
chromosomal damage evaluated in peripheral lymphocytes by classic cytogenetics and 
subsequent cancer risk. Chromosomal aberrations in peripheral blood lymphocytes are 
the only biomarkers that can provide information on the dose of exposure and associ­
ated risk of cancer, and they have been measured extensively in various circumstances. 
(1, 11). Recently introduced alkaline version of the comet assay (syn: single cell gel 
electrophoresis assay, SCGE assay) enables the assessment of genetic damage induced 
in vitro and in vivo in a great variety of cells (2, 15). In our study we compared responses 
to the challenging dose of X-rays of the lymphocytes collected from colorectal cancer 
patients and free of cancer controls on the molecular and mitotic levels using classic cy­
togenetics and DNA damage analysis by single cell gel electrophoresis assay (SCGE).
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Materials and methods
The study group consisted of 37 colorectal cancer patients (CCP), 17 females (average 
age 59.7) and 20 males (average age 62.6) and a group of 41 controls with various gas­
trointestinal disorders without cancer diagnosis (22 females, average age 55.5, and 19 
males, average age 58.5). Peripheral whole blood samples were collected into heparin- 
ized tubes and transported immediately to the laboratory of the Department of Radiation 
and Environmental Biology, Institute of Nuclear Physics, Polish Academy of Science. 
Information about donor’s health, lifestyles, diet and habits were collected through the 
questionnaires. In the study group there were 15.7% recent male smokers, 16.9% former 
smokers, and 14.5% non-smokers, and among women there were 14.5% recent smokers, 
8.4% former smokers, and 24.1% non-smokers.
Experimental procedure
Immediately after collecting blood for testing, the whole blood sample from each subject 
was divided for culturing and molecular studies.
DNA repair competence assay
For molecular studies, lymphocytes were isolated from the whole blood sample and 
cryopreserved for further treatment at -  80°C. Before the beginning of the experimental 
procedures cells were thawed according to the standard procedure and their viability was 
examined (2, 7). To evaluate individual susceptibility and repair competence, the extent 
of DNA damage was studied, using the alkaline version of the single cell gel electropho­
resis (SCGE) assay as described elsewhere (2), in defrosted lymphocytes, then after the 
irradiation, and after post irradiation incubation.
Irradiation of isolated lymphocytes
Isolated lymphocytes were irradiated with 3 Gy dose of X-rays from Philips MCN 323 
machine at 250 kV, 10mA. The dose rate applied was 1 Gy/min. The probes for DNA 
radiosensitivity studies were irradiated on a microscopic slides and the cells for DNA 
repair studies were irradiated simultaneously in the Eppendorf vials. To avoid DNA re­
pair process during irradiation, the temperature was maintained at below 4°C, and both, 
microscopic slides containing cells embedded in agarose and Eppendorf vials were po­
sitioned on a special polyethylene box containing ice cubes in water. Immediately after 
irradiation, microscopic slides with irradiated cells were immersed in lysing solution and 
cells that were irradiated in Eppendorf vials were placed in the box containing ice water 
bath. Then they were immediately transported to the laboratory, where cells irradiated 
in the Eppendorf vials were suspended with the 1 ml of medium (80% RPMI and 20% 
FBS) and transferred into an incubation chamber (37°C) for a period of 40 minutes, time 
specified in the DNA repair kinetics studies (2) as sufficient to complete fast repair in G0 
cells. After incubation cells were subjected to further steps of SCGE assay as described 
elsewhere (7) and residual (not repaired during the incubation) DNA damage was de­
tected.
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Detection of the DNA damage
The automatic analysis of the DNA in the comets was done using two parameters from 
the Komet 3.0 or Komet 5.5 software (Kinetic Imaging Company, Liverpool, UK):
• TDNA -  Tail-DNA (percentage of DNA in the comet tail).
• TM -  tail moment (which expresses the percentage of DNA in the tail multiplied 
by the tail length (TL) (TL means in our study the length of the comet tail mea­
sured from the edge of the comet head, the calibrated unit of tail length is about 
0.862 pm).
The result of the analysis was recorded as an average of two independent repetitive 
and independent electrophoreses performed by two researchers using Komet 3.0 or 5.5 
systems. For each experimental point, 100 cells were analyzed (25 from each of two 
different areas of a slide, together 50 cells from each slide). For analysis, SPSS and the 
statistical packages from MS Excel or Origin 7.0 software were applied.
To compare cellular DNA repair competence between individuals, DNA damage 
repair efficiency (RE) was defined as percent of DNA damage that was repaired during 
the post irradiation incubation, and it was presented as RET-DNA or RETL, for the DNA 
damage detection with the use of % of the DNA in the comet or comet tail length TL 
measures, and as RETM with the use of comet tail moment (TM) measures.
Internal standard (healthy donor cells)
To compare cellular capacities of patients and healthy donors, and to control stability of 
the experimental conditions and to avoid any influence of unpredictable factors on the 
quality of the final conclusions, an internal standard was put into operation as described 
earlier (7). Briefly, in each experiment and electrophoresis, a group of cells belonging 
to the same pool of cells from one sampling probe collected from a healthy male donor 
called ‘Mister Standard’ (MS), were subjected to the general procedure as the internal 
standard (IS). The male donor “MS” was selected as a representative from the historical 
control group investigated in previous studies (donors reporting none of health problems) 
(8). Standardizing factors were evaluated with respect to each electrophoresis (i) as the 
ratio of the results obtained from the response of standardizing cells to the challenging 
dose in that particular electrophoresis (i) (described as T-DNA3Gy0) to the average ob­
tained from the results of the IS cells (T-DNA3Gy(av)) from all experiments in those series 
of study. This resulted in a standardizing factor (SF) for experiment (i) estimated as fol­
lows: SF(i) = T-DNA3Gy(i)T-DNA3Gy(av). Then, all the results in each experiment (i) where 
divided by adequate standardizing factor SF^ and presented after standardization (7).
Irradiation of whole blood samples
A part of whole blood samples was settled in the box containing ice water bath and was 
treated as control. The other whole blood probes, placed in the heparinized small speci­
mens tube, were irradiated with 2 Gy dose of X-rays using Philips MCN 323 machine 
at 250 kV, 10 mA. The dose rate applied was 1 Gy/min. To avoid DNA repair during 
irradiation all blood samples were placed on a polyethylene box containing ice cubes in
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water. Immediately after irradiation, tubes with irradiated blood and not irradiated blood 
samples were again placed in the box containing ice water bath, transferred to the labora­
tory and subjected to culturing cytogenetic procedures.
Classic technique -  cytogenetics study
Classic cytogenetics culturing method used in the study was based on the procedures that 
are commonly used for monitoring genotoxic exposures, or for estimating a radiation 
dose absorbed by subjects involved in the radiation accidents in radiological protection 
laboratories (3, 6, 5, 12). For classic cytogenetics two probes/repetitions for chromosome 
aberrations (CA) and two probes for sister chromatid exchanges (SCE) were applied, an­
other four probes were used for fluorescence in situ hybridization (FISH) technique (two 
for irradiated cells and two for controls). All blood samples were incubated at 37°C using 
RPMI 1640 medium supplemented with 20% fetal calf serum, antibiotics, and various 
amounts of 5-bromo-2-deoxyuridine (BrdU), (0.05 mM for CA 0.075 mM for SCE and 
none for FISH techniques). All lymphocytes were stimulated with phytohemagglutinin 
PHA. Cultures designed for chromosome aberrations analysis were lasting 48 hours, and 
72 hours for SCE and FISH techniques. Two hours before the end of culturing, 0.1 pl/ml 
of colcemid solution was added to the culture to stop cells dividing in a proper stage of 
metaphase. Then, cells were fixed and stained with fluorescence plus Giemsa solution 
(for SCE and chromosome preparations) following a standard procedure described else­
where (17). Slides designed for further study with FISH technique were transferred to 
-20°C to store before the hybridization procedure with specific molecular and chromo­
some probes.
For screening of chromatid and chromosomal aberrations, only cells with identically 
dark-stained chromatids proving a first mitotic division were analyzed (6). Each good 
metaphase spread of lymphocytes was analyzed in the first mitosis for the presence of 
unstable chromosome aberrations (CA) and in the second division for sister chromatid 
exchanges. The frequency of chromosome aberrations was screened in at least 50-100 
good metaphase spreads (the number depending on the frequency of aberrations de­
tected). All types of chromosome damage were scored including gaps, breaks in chro­
mosomes and chromatids, fragments and chromatid exchanges. Based on these measure­
ments frequency of chromosome (CSA) and chromatid (CTA) aberrations were evalu­
ated (1). For the analysis of the SCE frequency, 50 metaphases in the second cell division 
were scored. PRI-proliferate rate index was evaluated from distributions of cells scored 
in the first (Mi), second M2 and third division (M3) according to the following formula: 
PRI = (Mj + 2xM2 + 3xM3) / (Mt + M2 + M3).
Statistics
Analysis of results was performed using Anova from statistical package for Social Sci­
ence (SPSS).
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Results and Discussion
In the Table 12.1 are shown mean values of cellular capacities evaluated for colorectal 
cancer patients (CCP = 1) and controls (CCP = 0), based on cells response to challeng­
ing dose of radiation and detection of chromosome and chromatid aberrations in the first 
mitotic division, stratified according to cancer diagnosis followed by stratification ac­
cording to the gender. Frequency of sister chromatid exchanges (SCE) and mitotic index, 
shown as PRI were measured in the cells without challenging radiation treatment.
Table 12.1. Mean values o f cellular capacities evaluated for groups of colorectal cancer patients 
(CCP = 1) and controls (CCP = 0) on the basis o f cells response to challenging dose o f radiation and de­
tection o f chromosome and chromatid aberrations in the first mitotic division stratified according to cancer 
diagnosis, followed by stratification to the gender and cancer diagnosis. Frequency o f sister chromatid 
exchanges (SCE) and mitotic index that are shown as PRI are measured in the cells without challenging 
radiation treatment
G CD n Age±SD
AbC
±SD
CTA1F
±SD
CTA2F
±SD
CTA
±SD
CSA
±SD
SCE ’
±SD
PRI’
±SD
All 0 41 56.9 49.4 3.17 69.0 72.9 37.0 4.54 2.22
13.14 10.66 2.82 19.71 20.80 12.28 1.21 .38
1 37 61.3 51.3 2.90 70.2 75.5 35.7 4.47 2.39
8.41 9.08 2.54 17.46 18.05 11.66 .97 .41
M 0 19 58.5 47.0 3.52 65.7 70.2 35.1 3.78 1.99
13.27 11.76 3.29 21.99 23.65 13.24 1.11 .284
1 20 62.6 49.3 2.67 68.7 71.8 37.5 3.83 2.45
6.72 9.30 2.23 21.15 21.27 11.25 .75 .29
F 0 22 55.5 51.6 2.86 72.1 75.5 38.7 5.11 2.57
13.17 9.28 2.36 17.31 17.97 11.45 .99 .15
1 17 59.7 53.8 3.20 74.9 79.7 36.8 4.96 2.36
10.40 8.85 2.96 12.44 12.98 9.99 .94 .52
G -  gender, M -  males, F -  females, CD -  Cancer diagnosis: 0 -  no cancer, control group, 1 -  colorectal cancer 
patients group, AbC -  percent of aberrant cells, CSA -  percentage of chromosome aberrations, CTA1F -  per­
centage of breaks in the one single chromatid, CTA2F -  percentage of acentric fragments from both chromatids, 
CTA -  percentage of all chromatid aberrations, SCE -  sister chromatid exchanges frequency per cell, PRI -  mi­
totic index [PRI= (M1 + 2M2 + 3M3) / (M1 + M2 + M3).
* No treatment.
In the whole group, colorectal cancer patients, both men and women, are slightly 
(about 4 years) older than controls. On the whole statistically no significant differences 
were observed in all cytogenetic endpoints between CCP and controls, however, differ­
ences between groups were slightly increasing after stratifying according to gender. The 
rate of aberrant cells in CCP group is slightly higher than in the controls (in the whole 
group, and in the both male and females subgroups). No difference between cancer pa­
tients and control groups were observed, without or with stratification according to gen­
der in the percent of breaks in the one single chromatid (CTA1F). Higher in CCP than in 
control frequencies of chromatid type aberrations that means acentric fragments (CTA2F)
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and all chromatid type of aberrations (CTA) were observed in the studied group as the 
whole, and in the both male and females subgroups.
There are no significant differences between cancer patients and controls in the fre­
quency of sister chromatid exchanges detected in the second mitotic division, neither 
without, nor after gender stratification. However, in general sister chromatid exchanges 
(SCE) among females are higher than in males, and it can be associated with less effi­
cient homologous recombination in females lymphocytes (16).
Results of the rate of aberrant cells, CSA, CTA and SCE (Fig. 12.1) show comparison 
between subgroups of cancer patients and controls separately for subgroups of males and 
females. The slight difference between CCP and controls or males and females is only 
visible in the frequency of chromatid breaks.
gender
male female
Figure 12.1. Mean values of cellular capacities evaluated for groups of colorectal cancer patients (CCP = 1) 
and controls (CCP = 0) on the basis of cells response to challenging dose of radiation and detection of 
chromosome and chromatid aberrations in the first (AbC, CTAF, CSA) or second mitotic division, then 
stratified according to gender followed by stratification according cancer diagnosis. Frequency of sister 
chromatid exchanges (SCE) are measured in the cells without challenging radiation treatment
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Table 12.2 shows mean values of the same biomarkers of cellular capacities evalu­
ated for investigated groups based on cells response to challenging dose of radiation, 
as shown in the Table 12.1. The results are stratified according to cancer diagnosis in 
the immediate family (CiF) then according to gender and finally colorectal cancer diag­
nosis. After stratification of the study group according to CiF factor and then to cancer 
diagnosis it appeared that five persons, who reported having relatives with documented 
cancers were all cancer patients. The number of patients, who report cancer in immediate 
family (CiF factor) is fairly low, and therefore it is unlikely to find statistically signifi­
cant influence of genetic predisposition, nevertheless, we observed in these cases higher 
frequency of chromatid type aberrations and slightly lower frequency of chromosome 
damage (dicentics and rings).
Table 12.2. Mean values of cellular capacities evaluated for groups of colorectal cancer patients (CCP = 1) 
and controls (CCP = 0) on the basis of cells response to challenging dose of radiation and detection of 
chromosome and chromatid aberrations in the first mitotic division stratified to cancer reports in the im­
mediate family and then to the gender and cancer diagnosis
CiF G CD n Age±SD
AbC
±SD
CTA1F
±SD
CTA2F
±SD
CTA
±SD
CSA
±SD
SCE
±SD
PRI
±SD
0 all All 73 59.2 50.2 3.08 73.7 69.9 37.7 4.45 2.37
11.70 10.16 11.05 22.06 19.24 12.22 1.09 .40
1 all All 5 56.8 54.3 3.35 78.5 73.3 29.8 5.19 2.41
6.83 6.89 2.04 11.83 13.20 9.12 .23 .61
0 all 0 41 56.9 49.6 3.18 73.0 69.1 37.0 4.57 2.35
13.30 10.72 2.86 21.09 19.99 12.46 1.27 .31
1 32 62.0 51.1 2.92 74.8 71.2 38.7 4.34 2.38
8.63 9.41 2.64 23.77 18.29 10.54 1.01 .40
1 all 0 nd nd nd nd nd nd nd Nd Nd
1 5 56.8 54.3 3.35 78.5 73.3 29.8 5.19 2.41
6.83 6.89 2.04 11.83 13.20 9.12 .23 .61
1 M 1 2 64.0 48.4 4.65 66.1 59.5 29.8 4.50 2.34
2.63 1.32 1.32 .00 7.89
F 1 3 52.0 58.3 2.48 86.8 82.5 29.8 5.19 2.41
2.64 5.68 2.15 4.68 5.68 11.62 .22 .60
0 M 0 19 58.5 47.3 3.55 70.2 65.7 35.0 4.07 2.27
13.63 12.03 3.39 24.40 22.66 13.66 1.11 .36
M 1 18 62.6 50.0 2.58 72.6 70.1 38.7 3.72 2.43
7.24 9.95 2.20 22.84 22.50 11.78 .69 .30
F 0 22 55.5 51.6 2.86 75.5 72.1 38.7 5.11 2.49
13.17 9.28 2.36 17.97 17.31 11.44 .99 .16
F 1 14 61.4 52.6 3.38 77.6 72.6 38.7 4.90 2.33
10.40 8.85 3.20 14.07 11.80 12.66 .94 .49
Abbreviations as in the Table 12.1. (Differences statistically insignificant after grouping variables by CiF factor 
withnonparametric tests (Mann-Whitney U, Wilcoxon W)
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This subgroup had the highest level of chromatid type damage, including highest 
level of SCE. The remaining patients might be considered as group with lower than oth­
ers probability of hereditary predisposition to cancer. After stratifications the subgroup 
of cancer patients, who had cancer reports in their families according to gender, a visibly 
lower age of expression of the disease was seen in females patients and much higher than 
in males level of chromatid type of the damage (except of frequency of single chromatid 
fragments).
When, the rest of the group (without documented cancer in family) was stratified ac­
cording to gender and finally to cancer diagnosis, the results of the rate of aberrant cells 
(AbC) and chromatid type of aberrations (CTA2F, CTA) were still visibly higher for CCP 
than for control group. Ages of cancer expression in that group is higher than average age 
of control group (both for females and males).
Table 12.3. Mean values of cellular capacities in groups of colorectal cancer patients (CCP = 1) and con­
trols (CCP = 0) evaluated from DNA repair competence assay before and after stratification according to 
the gender and cancer diagnosis
G CD n T-DNAx . rays±SD
™ X - r a y s
±SD
TLX-rays
±SD
R E t -d n a
±SD
R E t l
±SD
R E t m
±SD
All 0 35 30.06 35.34 66.13 92.10 79.09 94.64
6.93 11.80 22.24 22.29 34.26 23.78
1 26 27.19 31.38 58.85 86.70 70.63 88.46
8.04 14.87 26.42 25.95 29.13 26.74
M 0 18 30.42 35.50 69.36 92.35 78.98 95.30
7.12 11.61 19.23 22.00 31.62 22.42
1 15 28.70 34.35 64.70 91.24 78.42 93.91
8.78 16.76 28.40 27.40 33.14 28.30
F 0 17 29.68 35.17 62.70 91.83 79.20 93.94
6.92 12.35 25.18 23.27 37.84 25.82
1 11 25.14 27.34 50.87 80.51 60.00 81.04
6.75 11.32 22.24 23.37 19.17 23.69
T-DNAX-ray -  radiosensitivity of cells evaluated from immediate response to the challenging dose of X-rays, meas­
ured with SCGE technique and expressed as: T-DNA -  % of DNA in a comet, TM -  DNA tail moment, and TL 
-  DNA tail length, The RET-DNA express DNA damage repair efficiency (RE), defined as percent of DNA damage 
that was repaired during the post irradiation incubation and that was detected with the use of DNA measures 
(T-DNA, TM, TL -  % of DNA in a comet, tail moment or tail length respectively)
Mean values of cellular capacities in groups of colorectal cancer patients (CCP = 1) 
and controls (CCP = 0) evaluated from DNA repair competence assay before and after 
gender stratification are shown in the Table 12.3. Figures 12.2 and 12.3, show examples 
of variability between individual susceptibility to the DNA radiation damage and ef­
ficiency of the DNA repair in the compared groups. Figures 12.2a and 12.2b show the 
results of the cellular radiosensitivities (DNA damage detected in cells immediately after 
irradiation and measured as T-DNA(x-rays) (Fig. 12.2a) and TM(x-rays) (Fig. 12.2b), respec­
tively, for colorectal cancer patients described as the dispersion from average obtained 
for control group (T-DNAX-rays = 30.06 ± 6.93, TMX-rays = 35.34 ± 11.8). Figures 12.3a 
and 12.3b are show the results of the repair efficiency of the DNA damage induced
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Figure 12.2a. Dispersion (from mean value obtained for the control) of radiosensitivities evaluated from 
DNA damage detected in response to irradiation of lymphocytes from colorectal cancer patients (based 
on T-DNAXrays measures) described as the dispersion from average obtained for the control group 
(T-DNAX-rays = 30.06 ± 6.93)
Figure 12.2b. Dispersion (from mean value obtained for the control) of radiosensitivities evaluated from 
DNA damage detected in response to irradiation of lymphocytes from colorectal cancer patients (based 
on TMXrays measures) described as the dispersion from average obtained for the control group (TMXrays = 
35.34 ± 11.80)
by radiation for the colorectal cancer patients, evaluated for the T-DNA measures (Fig. 
12.3a) and TM (Fig. 12.3b), respectively, again described as the dispersion from average 
obtained for the controls (average RET-DNA = 92.10 ± 22.29, and RETM = 94.64 ± 23.78). 
In both groups of results, variability between individuals is rather high, and this affects 
a statistical power. Although, none of the differences between the results shown in the
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Table 12.3, that might differentiate either DNA sensitivities to challenging treatment or 
DNA repair efficiency are statistically significant, though, overall for all DNA measures 
(T-DNA, TM and TL), both radiosensitivity and DNA repair efficiency is lower in color­
ectal patients group.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38
Case Number
Figure 12.3a. Dispersion (from mean value of the DNA repair efficiency -  RE obtained for the control 
group) evaluated from the DNA damage detected after post irradiation incubation in lymphocytes from 
colorectal cancer patients (based on T-DNArep measures) described as the dispersion from average ob­
tained for the control group (RET-DNA = 92.10 ± 22.29)
i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38
Case Num ber
Figure 12.3b. Dispersion (from mean value of the DNA repair efficiency -  RE obtained for the control 
group) evaluated from the DNA damage detected after post irradiation incubation in lymphocytes from 
colorectal cancer patients (based on T-DNArep measures) described as the dispersion from average ob­
tained for the control group (RET-DNA = 94.64 ± 23.78)
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When results are stratified according to the gender, then, cellular capacities in con­
trol subgroups show comparable values between males and females. Sensitivity to chal­
lenging treatment is lower in lymphocytes of females (i.e., TLX-rays -  males 66.9 vs. 
62.5 females), however, in CCP groups, females expressed lower than males percentage 
of the repaired DNA damage (RET-DNA -  CCP males 91.2% vs. 80.5% females, RETM 
-  93.9% males vs. 81.0% females, and RETL -  78.4% vs. 60.0%, respectively). This may 
correspond to the results from cytogenetics studies (Table 12.1) where in a group of CCP 
females, higher cytogenetic damage was observed.
Table 12.4 shows mean values of cellular capacities in groups of colorectal cancer pa­
tients (CCP = 1) and controls (CCP = 0 ) evaluated from DNA repair competence assay 
after stratification according to cancer incidence in the immediate families (CiF), then 
according to gender, and cancer diagnosis. Again, all factors measured with the SCGE 
assays are insignificantly lower in the whole group of CCP patients than in the controls.
Table 12.4. Mean values o f cellular capacities in groups o f colorectal cancer patients (CCP = 1) and 
controls (CCP = 0) evaluated from DNA repair competence assay after stratification according to cancer 
incidence appearing in immediate families (CiF), gender and cancer diagnosis
CiF Gender CD n T-DNA x -ra ys±SD
TM X-rays
±SD
TLX-rays
±SD
R E t -d n a
±SD
R E t l
±SD
R E t m
±SD
1 26 27.19 31.38 58.85 86.70 70.63 88.46
1 all all 4 23.65 27.82 55.84 76.85 54.63 77.31
8.09 14.42 26.42 23.98 29.80 29.61
0 all all 56 28.07 31.76 59.99 86.79 72.22 88.72
3.48 7.88 16.01 11.44 21.81 10.20
1 M 1 2 25.20 30.44 58.91 75.99 56.22 76.79
9.82 20.62 26.62 31.57 36.99 37.04
F 1 2 22.11 25.21 52.77 77.71 53.05 77.83
9.51 13.08 36.71 26.93 35.87 35.46
0 M 0 17 30.17 35.17 69.25 91.03 76.51 93.62
7.26 11.87 19.82 21.94 30.74 21.91
1 13 29.24 34.95 65.60 93.59 81.84 96.54
8.92 17.01 29.59 27.35 32.75 27.64
0 F 0 17 29.68 35.17 62.71 91.83 79.20 93.94
6.92 12.35 25.18 23.27 37.84 25.82
1 9 25.82 27.81 50.45 81.13 61.54 81.76
6.55 11.73 21.19 24.28 16.85 23.27
Abbreviations as in the Table 12.3. (Differences statistically insignificant after grouping variables by CiF factor 
with nonparametric tests (Mann-Whitney U, Wilcoxon W)
The results from molecular analyses show similar pattern as observed in cytogenetics 
studies. CCP patients who were reporting cancers in their immediate family (CiF = 1) 
have shown much lower efficiency of DNA repair (in all measures T-DNA, TM, TL) 
than the rest of the studied group, and than the other CCP group (CiF = 0), although 
cellular sensitivity to radiation damage of those patients is also lower. Females, from 
control group (CiF = 0 and CD = 0) show similar to men sensitivity and DNA repair ef­
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ficiency. Group of CCP females without cancer cases in the immediate family (CiF = 0), 
expressed lower DNA repair efficiency than males from the same group, in spite of 
slightly lower radiosensitivity.
Our results from classic cytogenetic analysis of lymphocytes from colorectal cancer 
patients showed higher than in controls level of chromatid type of damage, and slightly 
lower level of chromosome types (dicentrics, rings and acentric fragments). Cytogenetic 
results, to some extent, are consistent with the amount of unrepaired DNA damage in­
duced by experimental treatment. A  efficiency of DNA repair evaluated by the Comet 
assay does not necessarily determine fidelity of repaired DNA. Therefore, slower and 
less efficient DNA repair process observed in lymphocytes of colorectal cancer patients 
might be associated with higher amount of misrepaired DNA that would result in chro­
mosome aberrations. This suggestion is confirmed by higher percent of induced aberrant 
cells and higher frequency of chromosome aberrations. Cytogenetic damage and defi­
ciency in DNA repair show also association with smoking and sport activities (results not 
shown). Nevertheless, our findings need deeper molecular insight and further studies in 
larger populations and more homogenic, in terms of gender, smoking and other lifestyle 
factors, like diet, crucial for this type of dissease. According to Gonzalgo et al. (10), an 
alternative sign of pathway to cancer in addition to aneuploidy, loss of heterozygosity 
and gene mutations and the identification of molecular markers specific to early and late 
events in cancer progression is critical for the development of improved detection and 
prognostic strategies (7). Low statistical power of differences between CCP and control, 
can also be associated to recent findings by Delongchamps N.B. et al. (19) who have 
shown that benign prostatic hyperplasia but not prostate cancer was directly associated 
with the presence of chronic inflammation (12). It is possible that lymphocytes from 
CCP patients are stimulated to show strong abilities to repair DNA damage, however, 
cells from patients suffering with temporary infection also are less capable, because of 
presence of competing chronic inflammation process in the same conditions.
The results obtained from molecular and cytogenetic studies should confirm that 
evaluation of cellular sensitivity and repair competence could have an important value 
for pre-clinical studies, and that cellular DNA repair efficiency evaluated by SCGE as­
say may identify patients more sensitive or resistant to therapeutic treatment. The repair 
competence assay can provide such information during one day from collection of the 
biological sample. Our suggestion is important from clinical point of view, because clas­
sic cytogenetic biomarkers, although excellent and reliable, are extremely time consum­
ing. Further and deeper studies are needed to improve statistics and fully understand 
mechanisms involved in various associations between molecular and cellular responses 
expressed in our studies.
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